“Nobody Was Armed At NCI”: US FDA Head Sharpless Adjusts To Life As Regulator
Acting commissioner is entering the usual learning curve for new leaders of the agency. It’s a reminder of how unusual it was to skip that step under his predecessor.
You may also be interested in...
The messaging around the US FDA commissioner transition has emphasized continuity and business-as-usual. But this is still all pretty weird.
In his first speech to an outside group, Sharpless strikes a collaborative tone, saying he expects to listen to the advice of the FDA bar, as well as his own experts.
Acting US FDA commissioner Norman Sharpless outlines some key differences between his new position and his former role at the NCI.